Abbott Laboratories (ABT) Other Operating Expenses (2009 - 2026)

Abbott Laboratories' Other Operating Expenses history runs 18 years deep, the most recent figure standing at $5.3 billion for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 8.67% year-over-year to $5.3 billion; the TTM figure through Mar 2026 stood at $21.4 billion (up 4.32% YoY), while the FY2025 annual figure was $21.0 billion, up 2.03% from the prior year.
• Other Operating Expenses came in at $5.3 billion for Q1 2026 at Abbott Laboratories, down from $5.3 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.5 billion in Q1 2022 to a low of $4.8 billion in Q1 2023.
• A 5-year average of $5.2 billion and a median of $5.1 billion in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses rose 12.0% in 2022 and declined 12.31% in 2023, its largest moves.
• Abbott Laboratories' Other Operating Expenses stood at $5.1 billion in 2022, then declined by 1.02% to $5.0 billion in 2023, then increased by 7.35% to $5.4 billion in 2024, then declined by 1.17% to $5.3 billion in 2025, then slipped by 0.6% to $5.3 billion in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $5.3 billion, $5.3 billion, and $5.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison